Profile
Dirk Van Hyfte is the founder of BioStrand BV, which is founded in 2019, where he holds the title of Chief Technology Officer.
He is currently the Director at BioKey BV since 2020 and at BioClue BV since 2019.
Dirk Van Hyfte active positions
Companies | Position | Start |
---|---|---|
BioClue BV
BioClue BV Medical/Nursing ServicesHealth Services Founded in 2019, BioClue BV is a subsidiary of ImmunoPrecise Antibodies Ltd. that provides biotechnology services and specializes in the development of antibody therapeutics. The company is based in Hamont-Achel, Belgium. | Director/Board Member | 05/02/2019 |
BioKey BV
BioKey BV Real Estate DevelopmentFinance Part of ImmunoPrecise Antibodies Ltd., BioKey BV is a company based in Hamont-Achel, Belgium. | Director/Board Member | 14/05/2020 |
BioStrand BV
BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Founder | 05/02/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
BioClue BV
BioClue BV Medical/Nursing ServicesHealth Services Founded in 2019, BioClue BV is a subsidiary of ImmunoPrecise Antibodies Ltd. that provides biotechnology services and specializes in the development of antibody therapeutics. The company is based in Hamont-Achel, Belgium. | Health Services |
BioKey BV
BioKey BV Real Estate DevelopmentFinance Part of ImmunoPrecise Antibodies Ltd., BioKey BV is a company based in Hamont-Achel, Belgium. | Finance |
BioStrand BV
BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Commercial Services |
- Stock Market
- Insiders
- Dirk Van Hyfte